中興通訊(00763.HK)完成發行10億元超短融(科創票據)
格隆匯8月4日丨 中興通訊(00763.HK)公佈,2022年8月4日,公司按面值完成了2022年度第三十二期超短融(科創票據)的發行。2022年度第三十二期超短融(科創票據)發行額為10億元人民幣,期限為57天,單位面值為100元人民幣,發行利率為1.77%,起息日期為2022年8月4日,兑付日期為2022年9月30日,渤海銀行股份有限公司為主承銷商,中國民生銀行股份有限公司為聯席主承銷商。2022年8月4日,2022年度第三十二期超短融(科創票據)所募集的資金已經全部到賬,將用於兑付承兑匯票。
截至2022年8月4日,公司已發行尚未到期的超短融(含2022年度第三十二期超短融)合計為120億元人民幣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.